Trials / Conditions / RAF Mutation
RAF Mutation
5 registered clinical trials studyying RAF Mutation — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (M NCT06287463 | Deciphera Pharmaceuticals, LLC | Phase 1 |
| Recruiting | PAS-004 in Patients With Advanced Solid Tumors NCT06299839 | Pasithea Therapeutics Corp. | Phase 1 |
| Terminated | Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors. NCT05831995 | ABM Therapeutics Corporation | Phase 1 |
| Terminated | Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors NCT07121829 | Day One Biopharmaceuticals, Inc. | Phase 1 |
| Terminated | Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors NCT04985604 | Day One Biopharmaceuticals, Inc. | Phase 2 |